Literature DB >> 1314578

Expression of MBP-HCV NS1/E2 fusion protein in E. coli and detection of anti-NS1/E2 antibody in type C chronic liver disease.

E Mita1, N Hayashi, K Ueda, A Kasahara, H Fusamoto, A Takamizawa, K Matsubara, H Okayama, T Kamada.   

Abstract

To characterize the putative NS1/E2 (non-structural protein 1/envelope 2) domain of HCV (hepatitis C virus), we expressed the hydrophilic three-quarters of this domain in a form of MBP (maltose binding protein) fusions in Escherichia coli. When we checked the positive frequency of antibody to this fusion protein, 17% of patients with type C chronic liver disease had this antibody. However, they were all positive for HCV-RNA in sera. These results suggest that the appearance of anti-NS1/E2 antibody does not serve as evidence of viral clearance.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1314578     DOI: 10.1016/s0006-291x(05)80278-5

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  High-level expression of the C-terminal hydrophobic region of HCV E2 protein ectodomain in E. coli.

Authors:  Jing Liu; Yuying Kong; Lixin Zhu; Yuan Wang; Guangdi Li
Journal:  Virus Genes       Date:  2002       Impact factor: 2.332

2.  Peptide immunogen mimicry of putative E1 glycoprotein-specific epitopes in hepatitis C virus.

Authors:  R Ray; A Khanna; L M Lagging; K Meyer; Q L Choo; R Ralston; M Houghton; P R Becherer
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

3.  Occurrence of antibodies reactive with more than one variant of the putative envelope glycoprotein (gp70) hypervariable region 1 in viremic hepatitis C virus-infected patients.

Authors:  E Scarselli; A Cerino; G Esposito; E Silini; M U Mondelli; C Traboni
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.